UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060427
Receipt number R000069024
Scientific Title A safety study on long-term consumption of a yogurt drink.
Date of disclosure of the study information 2026/01/22
Last modified on 2026/01/21 17:49:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A safety study on long-term consumption of a yogurt drink.

Acronym

A safety study on long-term consumption of a yogurt drink.

Scientific Title

A safety study on long-term consumption of a yogurt drink.

Scientific Title:Acronym

A safety study on long-term consumption of a yogurt drink.

Region

Japan


Condition

Condition

N/A

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the safety of 12 weeks consumption of a yogurt drink in a randomized, double-blind, placebo-controlled, parallel-group trial.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Number of subjects and events for adverse events (AEs) and for AEs related to the study products.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Oral intake of the test food (yogurt drink, 112 g) once daily for 12 weeks.

Interventions/Control_2

Oral intake of placebo food (acidified milk, 112 g) daily for 12 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

(1) Healthy Japanese male and female aged 20 to 64 years at the time of consent.
(2) Subjects with a BMI >= 18.5 and < 30.0.
(3) Subjects who provide written informed consent.

Key exclusion criteria

(1) Subjects who have serious disease.
(2) Subjects who have taken any medication within 3 days prior to the screening test.
(3) Subjects with an average daily alcohol intake exceeding 40 g.
(4) Subjects unable to abstain from alcohol for 1 day prior to the examination.
(5) Subjects whose daily routines are irregular due to night work or shift work.
(6) Subjects who are expected to be unable to consume the study food for 6 or more days due to extended travel or similar circumstances.
(7) Subjects have participated in other research within 4 weeks prior to consent or plan to participate in other research after consent.
(8) Subjects who are pregnant, breastfeeding or intend to become pregnant during this study.
(9) Subjects who tend to develop diarrhea after consuming dairy products.
(10) Subject with food allergies.
(11) Subjects who donated blood component or 200 mL of whole blood within 1 month before this study.
(12) Males who donated 400 mL of whole blood within 3 months before this study.
(13) Females who donated 400 mL of whole blood within 4 months before this study.
(14) Males whose total blood draw volume, including the planned volume for this study, exceeds 1,200 mL within 12 months before this study.
(15) Females whose total blood draw volume, including the planned volume for this study, exceeds 800 mL within 12 months before this study.
(16) Subjects deemed unsuitable by the investigator.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Shukuko
Middle name
Last name Ebihara

Organization

Chiyoda Paramedical Care Clinic

Division name

Director

Zip code

103-0021

Address

2F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo

TEL

03-6225-9505

Email

cpcc-contact@cpcc.co.jp


Public contact

Name of contact person

1st name Makoto
Middle name
Last name Ichinohe

Organization

CPCC Company Limited

Division name

Director

Zip code

103-0021

Address

4F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo

TEL

03-6625-9001

Homepage URL


Email

cpcc-contact@cpcc.co.jp


Sponsor or person

Institute

CPCC Company Limited

Institute

Department

Personal name



Funding Source

Organization

Meiji Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Chiyoda Paramedical Care Clinic

Address

2F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo 103-0021, Japan

Tel

03-6225-9005

Email

IRB@cpcc.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 01 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 10 Month 27 Day

Date of IRB

2025 Year 10 Month 24 Day

Anticipated trial start date

2026 Year 01 Month 23 Day

Last follow-up date

2026 Year 04 Month 17 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 01 Month 21 Day

Last modified on

2026 Year 01 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069024